Companies: 10,795·Total market cap: $144.5T
Ambrx Biopharma Inc.

Ambrx Biopharma Inc.

AMAMNYSEHealthcare
$28.00
+$0.02(+0.07%)
Market Cap$1.8B
P/E Ratio
52W High$28.15
52W Low$6.55
Overview

Ambrx Biopharma Inc. (AMAM) · Balance Sheet

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · AMAM · as of 2026-06-10

Financial statements

Total Assets · Total Liabilities · Equity
Breakdown2022-122021-122020-122019-12
Assets
Cash & ST Investments$84.48M$170.06M$90.46M$15.49M
Net Receivables$2.05M$1.34M$0.98M$1.39M
Inventory$3.73M$5.17M$1.44M$1.13M
Total Current Assets$90.58M$176.81M$93.08M$18.16M
PP&E Net$14.01M$15.72M$3.49M$4.97M
Goodwill$0.00M$0.00M$0.00M$0.00M
Intangible Assets$25.25M$35.96M$36.83M$38.28M
Total Assets$146.98M$229.02M$134.02M$61.73M
Liabilities
Short-Term Debt$1.73M$0.92M$1.59M$1.45M
Accounts Payable$3.21M$5.27M$2.82M$5.39M
Total Current Liabilities$16.66M$24.58M$13.26M$14.94M
Long-Term Debt$10.24M$12.21M$1.60M$3.19M
Total Liabilities$29.13M$39.05M$272.17M$25.74M
Stockholders Equity
Retained Earnings($291.63M)($213.63M)($145.55M)($129.01M)
Total Stockholders Equity$117.85M$189.97M($139.43M)$33.42M
Total Liab & Equity(computed)$146.98M$229.02M$132.73M$59.16M
Debt Summary
Total Debt$11.98M$13.13M$3.19M$4.65M
Net Debt($43.63M)($156.94M)($87.27M)($10.85M)

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M

Explore more Ambrx Biopharma Inc. data

About Ambrx Biopharma Inc. (AMAM) Balance Sheet

Ambrx Biopharma Inc. (AMAM) balance sheet shows total assets of $0.15B with cash of $0.08B. Total liabilities are $0.03B, total debt $0.01B, and stockholders equity $0.12B.

Frequently asked questions

AMAM · 4 questions

Ambrx Biopharma Inc. has total debt of $0.01B with net debt of ($0.04B).

AMAM total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10